Cytomegalovirus infection of the liver transplant: Virological, histological, immunological, and clinical observations

Transplant Infectious Disease

Volumn 8, Issue 1, 2006, Pages 21-30

  Lautenschlager, I ^a   Halme, L ^a   Hockerstedt K ^a   Krogerus, L ^a   Taskinen, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adhesion molecules; CMV; Liver transplantation; Lymphocyte activation

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CYCLOSPORIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GANCICLOVIR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SIALYL LEWIS X ANTIGEN; STEROID; TSUKUBAENOLIDE; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; VIRUS ANTIGEN; VIRUS DNA;

ACUTE GRAFT REJECTION; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CELL ACTIVATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DNA HYBRIDIZATION; GRAFT INFECTION; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFECTION PREVENTION; KUPFFER CELL; LIVER ABSCESS; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER PARENCHYMA; LIVER TRANSPLANTATION; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIREMIA; VIROLOGY;

ADULT; ANTIGENS, VIRAL; BIOPSY; CELL ADHESION MOLECULES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR ADHESION MOLECULE-1; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33645722366     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00122.x     Document Type: Article

References (22)

1. Patel R Paya C. Cytomegalovirus infection and disease in solid organ transplant recipients. In Bowden RA Ljungman P Paya CV eds. Transplant Infections. Philadelphia Lippincott-Raven Publishers 1998 229 244.
2. Kanj SS Sharara AI Clavien PA Hamilton JD. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis 1996 22 537 549.
3. Seehofer D Rayes N Tullius SG et al. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl 2002 8 1138 1146.
4. Paya C Humar A Dominguez E et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 4 611 620.
5. Limaye AP Bakthavatsalam B Kim HW et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 2004 78 1390 1396.
6. Sign N Wannstedt C Keyes L Gayowski T Wagener MM Cacciarelli TV. Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact of viral load and late-onset cytomegalovirus disease. Transplantation 2005 79 85 90.
7. Barkholt LM Ehrnst A Veress B. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens. Scand J Gastroenterol 1994 29 553 560.
8. Colina F Juca NT Moreno E et al. Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol 1995 42 351 357.
9. Arnold JC Portman BC O'Grady JG Naoumov NV Alexander GJM Williams R. Cytomegalovirus infections persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992 16 285 292.
10. Lautenschlager I Höckerstedt K Jalanko H et al. Persistent CMV in liver allografts with chronic rejection. Hepatology 1997 25 190 194.
11. Evans PC Coleman N Wreghitt TG Wight DGD Alexander GJM. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol 1999 31 913 920.
12. Cainelli F Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2002 2 539 549.
13. Rubin RH. The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management. Curr Clin Top Infect Dis 2002 22 125 154.
14. Steinhoff G Behrend M Schrader B Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology 1993 18 440 453.
15. Lautenschlager I Höckerstedt K Taskinen E von Willebrand E. Increased expression of adhesion molecules in liver allografts during cytomegalovirus infection. Transplant Immunol 1996 4 59 60.
16. The TH van der Berg AP Harmsen MC van der Bij W van Son WJ. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis 1995 99 S25 S29.
17. An International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997 25 658 663.
18. Halme L Höckerstedt K Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003 75 1853 1858.
19. Madalosso C de Suoza NF Ilstrup DM Wiesner RH Krom RAF. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998 66 294 297.
20. Martelius T Krogerus L Höckerstedt K Bruggeman C Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology 1998 27 996 1002.
21. MacDonald GA Greenson JK DelBuono EA et al. Mini-microabscess syndrome in liver transplant recipients. Hepatology 1997 26 192 197.
22. Lamps LW Pinson CW Raiford DS Shyr Y Scott MA Washingtom MK. The significance of microabscesses in liver transplant biopsies: a clinicopathological study. Hepatology 1998 28 1532 1537.